Stecker

SeaChange International Appoints Veteran Technology Executive Matthew Stecker to Board of Directors

Retrieved on: 
Thursday, February 11, 2021
Articles, Digital television, SeaChange International, Board of directors, Stecker, Sea change, Business

WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, today announced that its Board of Directors has appointed veteran technology executive Matthew Stecker to the Board of Directors, effective February 10, 2021.

Key Points: 
  • WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, today announced that its Board of Directors has appointed veteran technology executive Matthew Stecker to the Board of Directors, effective February 10, 2021.
  • Stecker replaces Andrew Sriubas, who was appointed to the Board of Directors in 2016.
  • Stecker comes to SeaChange with over 30 years of experience in the software, services, and mobile industries.
  • On behalf of the entire organization, I would like to welcome Matthew to SeaChanges Board of Directors, said Executive Chairman Robert Pons.

Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.

Retrieved on: 
Wednesday, December 9, 2020
Legal, Professional services, Stecker, Shuman

Shuman, Glenn & Stecker announces that it is investigating potential claims against certain officers and directors of Zynerba Pharmaceuticals, Inc. (Zynerba or the Company) (NASDAQ: ZYNE ).

Key Points: 
  • Shuman, Glenn & Stecker announces that it is investigating potential claims against certain officers and directors of Zynerba Pharmaceuticals, Inc. (Zynerba or the Company) (NASDAQ: ZYNE ).
  • In 2018, Zynerba began a Phase II clinical trial of Zygel in children and adolescents with developmental and epileptic encephalopathies (DEE).
  • If you currently own Zynerba common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman, Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman, Glenn & Stecker Investigates Ryder System, Inc.

Retrieved on: 
Tuesday, October 20, 2020
Legal, Professional services, Ryder, Stecker, Transport

Shuman, Glenn & Stecker announces it is investigating potential shareholder claims against certain officers and directors of Ryder System, Inc. (Ryder or the Company) ( NYSE: R ).

Key Points: 
  • Shuman, Glenn & Stecker announces it is investigating potential shareholder claims against certain officers and directors of Ryder System, Inc. (Ryder or the Company) ( NYSE: R ).
  • On July 30, 2019, Ryder reduced its 2019 earnings forecast due to weaker valuations of its tractors.
  • If you currently own Ryder common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman, Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman, Glenn & Stecker Investigates Nutanix, Inc.

Retrieved on: 
Friday, September 18, 2020
Legal, Professional services, Financial markets, Cloud storage, Nutanix, Financial economics, Stecker, Shuman, Stock, Finance

Shuman, Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Nutanix, Inc. (Nutanix or the Company) (NASDAQ: NTNX ).

Key Points: 
  • Shuman, Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Nutanix, Inc. (Nutanix or the Company) (NASDAQ: NTNX ).
  • In reality, Nutanix was experiencing unprecedented sales force attrition and flattened spending on lead generation, while redirecting Company funds to R&D.
  • On this news, the Companys stock price fell $16.39 per share, or more than 32%, to close at $33.70.
  • If you currently own Nutanix common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected]
    Shuman, Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates The RealReal, Inc.

Retrieved on: 
Tuesday, September 15, 2020
Legal, Professional services, Financial markets, Corporate finance, Equity securities, Financial economics, Finance, The RealReal, Stecker, Stock, Initial public offering, Common stock

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of The RealReal, Inc. (RealReal or the Company) (Nasdaq: REAL ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of The RealReal, Inc. (RealReal or the Company) (Nasdaq: REAL ).
  • As the truth about RealReals authentication process began to leak out following the IPO, its stock price declined significantly.
  • If you currently own RealReal common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates AnaptysBio, Inc.

Retrieved on: 
Monday, August 24, 2020
Legal, Professional services, Medical specialties, Medicine, Clinical medicine, Food allergies, Immune system, Immunology, RTT, Peanut allergy, Allergy, Stecker

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of AnaptysBio, Inc. (AnaptysBio or the Company) (Nasdaq: ANAB ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of AnaptysBio, Inc. (AnaptysBio or the Company) (Nasdaq: ANAB ).
  • The Firms investigation relates to alleged misrepresentations regarding the Companys drug known as etokimab for the treatment of eczema, as well as peanut allergies.
  • On March 26, 2018, AnaptysBio announced data from an interim analysis of a Phase 2a trial for etokimab in patients with peanut allergies.
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates Corcept Therapeutics, Inc.

Retrieved on: 
Wednesday, August 5, 2020
Legal, Professional services, Corcept Therapeutics, Stecker

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Corcept Therapeutics, Inc. (Corcept or the Company) (Nasdaq: CORT ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Corcept Therapeutics, Inc. (Corcept or the Company) (Nasdaq: CORT ).
  • In its report, FFJ alleged a Company-wide off-label marketing scheme involving a Corcept drug called Korlym.
  • If you currently own Corcept common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates Granite Construction Inc.

Retrieved on: 
Thursday, June 25, 2020
Legal, Professional services, Granite Construction, Watsonville, California, GVA, Shuman, Stecker, Lao kip, Granite, Visual arts

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Granite Construction Inc. (Granite Construction or the Company) (NYSE: GVA ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Granite Construction Inc. (Granite Construction or the Company) (NYSE: GVA ).
  • Granite Construction is an infrastructure contractor and a construction materials producer in the United States.
  • If you currently own Granite Construction common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Kip Shuman toll free at (866) 569-4531 or email Mr. Shuman at [email protected] .
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates Advance Auto Parts, Inc.

Retrieved on: 
Wednesday, March 25, 2020
Legal, Professional services, Advance Auto Parts, Stecker, Shuman

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Advance Auto Parts, Inc. (Advance Auto Parts or the Company) (NYSE: AAP ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Advance Auto Parts, Inc. (Advance Auto Parts or the Company) (NYSE: AAP ).
  • Advance Auto Parts sells automotive replacement parts and accessories online and in stores across North America.
  • If you currently own Advance Auto Parts common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Shuman Glenn & Stecker Investigates Match Group, Inc.

Retrieved on: 
Thursday, March 5, 2020
Legal, Professional services, Stecker, Match Group, Shuman

Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Match Group, Inc. (Match or the Company) (Nasdaq: MTCH ).

Key Points: 
  • Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Match Group, Inc. (Match or the Company) (Nasdaq: MTCH ).
  • Match provides dating products through various website and mobile applications.
  • If you currently own Match common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at [email protected] .
  • Shuman Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.